BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer-Reference-Cited by-同舟云学术

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer

Published:2022-11-15 Issue:22 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Li Kun^ORCID,Liu Yanan,Ding Yi,Zhang Zhengwei,Feng Juanjuan,Hu Jiaxin,Chen Jiwei,Lian Zhengke,Chen Yiliang,Hu Kewen,Chen Zhi,Cai Zhenyu,Liu Mingyao^ORCID,Pang Xiufeng^ORCID

Funder

National Natural Science Foundation of China

Innovative Research Team of High-level Local Universities in Shanghai

Jointed PI Program from Shanghai Changning Maternity and Infant Health Hospital

ECNU Construction Fund of Innovation and Entrepreneurship Laboratory

ECNU multifunctional platform for innovation

MOE Key Laboratory of Biosystems Homeostasis & Protection

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/161308/files/pdf

Reference61 articles.

1. Cancer statistics, 2022

2. Lung cancer

3. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

4. Sotorasib for Lung Cancers with KRAS p.G12C Mutation

5. Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNAs in human diseases;MedComm;2024-09

2. The HOXC10/NOD1/ERK axis drives osteolytic bone metastasis of pan-KRAS-mutant lung cancer;Bone Research;2024-08-27

3. Application and research progress of cordycepin in the treatment of tumours (Review);Molecular Medicine Reports;2024-07-08

4. Highly expressed of BID indicates poor prognosis and mediates different tumor microenvironment characteristics in clear cell renal cell carcinoma;Discover Oncology;2024-05-20

5. Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis;Nature Communications;2024-05-15